Hledání článků
Filtry
Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MWY, et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 10.1681/ASN.2011121201.
Thadhani R, Appelbaum E, Pritchett Y, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease. The PRIMO randomized controlled trial. JAMA 2012;307:674–684.
Kielstein JT, Suntharalingam M, Perthel R et al. Asymmetric dimethylarginine may mediate increased heat pain threshold in experimental chronic kidney disease. Nephrol Dial Transplant 2012;27:899–902.
Kosmadakis C, John SG, Clapp EL, et al. Benefits of regular walking exercise in advanced pre‑dialysis chronic kidney disease. Nephrol Dial Transplant 2012;27:997–1004.
Frank Ch, Werber D, Cramer JP, et al., for the HUS Investigation Team. Epidemic profile of Shiga‑toxin‑producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011;365:1771–1780.
Cruzado JM, Poveda R, Ibernón M, et al. Low‑dose sirolimus combined with angiotensin‑converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy. Nephol Dial Transplant 2011;26:3596–3602.
Rovin BH, Furie R, Latinis K, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The LUpus Nephritis Assessment with Rituximab (LUNAR) Study. Arthritis Rheum 2012; e‑pub ahead of print.
Foley RN, Gilbertson DT, Murray T, et al. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011; 365:1099–1107.
Hecking M, Karaboyas A, Saran R, Sen A, Hörl WH, Pisoni RL, Robinson BM, Sunder‑Plassmann G, Port FK. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2012;59:238–248.
Kopple JD, Cheung AK, Christiansen JS, et al. OPPORTUNITY™: a large‑scale randomized clinical trial of growth hormone in hemodialysis patients. Nephrol Dial Transplant 2011;26:4095–4103.
Westenfeld R, Schlieper G, Woltje M, et al. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis – implications for post‑transplant bone disease. Nephrol Dial Transplant 2011;26:4115–4123.
Choukroun G, Kamar N, Dussol B, et al., for the CAPRIT study Investigators. Correction of postkidney transplant anemia reduces progression of allograft nephropathy. J Am Soc Nephrol 2012;23:360–368.